Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus for Social Abilities in PHTS
NCT06080165Phase 2Withdrawn
- Sponsor
- Stanford University
- Start
- Jul 2024
- Primary completion
- Jun 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in PTEN hamartoma tumor syndrome (PHTS), sponsored by Stanford University. Planned start Jul 2024; status: withdrawn.
02
Drugs
sirolimus
03
Conditions
PTEN hamartoma tumor syndrome (PHTS)
Beyond the preview
Go deeper on NCT06080165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06080165.